Prenatal DEHP exposure predicts neurological disorders via transgenerational epigenetics

Sci Rep. 2023 May 6;13(1):7399. doi: 10.1038/s41598-023-34661-3.

Abstract

Recent experimental and observational research has suggested that childhood allergic asthma and other conditions may be the result of prenatal exposure to environmental contaminants, such as di-(2-ethylhexyl) phthalate (DEHP). In a previous epidemiological study, we found that ancestral exposure (F0 generation) to endocrine disruptors or the common plasticizer DEHP promoted allergic airway inflammation via transgenerational transmission in mice from generation F1 to F4. In the current study, we employed a MethylationEPIC Beadchip microarray to examine global DNA methylation in the human placenta as a function of maternal exposure to DEHP during pregnancy. Interestingly, global DNA hypomethylation was observed in placental DNA following exposure to DEHP at high concentrations. Bioinformatic analysis confirmed that DNA methylation affected genes related to neurological disorders, such as autism and dementia. These results suggest that maternal exposure to DEHP may predispose offspring to neurological diseases. Given the small sample size in this study, the potential role of DNA methylation as a biomarker to assess the risk of these diseases deserves further investigation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Asthma* / chemically induced
  • Asthma* / epidemiology
  • Child
  • Diethylhexyl Phthalate* / toxicity
  • Endocrine Disruptors*
  • Epigenesis, Genetic
  • Female
  • Humans
  • Maternal Exposure / adverse effects
  • Mice
  • Nervous System Diseases* / chemically induced
  • Nervous System Diseases* / genetics
  • Placenta
  • Pregnancy
  • Prenatal Exposure Delayed Effects* / chemically induced
  • Prenatal Exposure Delayed Effects* / genetics

Substances

  • Diethylhexyl Phthalate
  • Endocrine Disruptors